ThromboGenics NV is set explore a new target for the treatment of ophthalmic diseases following the signing of an exclusive licensing deal with venture capital-backed Bicycle Therapeutics of the UK. Financial terms were not disclosed. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
